HO-PEG16-OH

CAS No. 6812-36-8

HO-PEG16-OH ( —— )

Catalog No. M26964 CAS No. 6812-36-8

HO-PEG16-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 82 In Stock
100MG 125 In Stock
200MG 178 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HO-PEG16-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    HO-PEG16-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    HO-PEG16-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6812-36-8
  • Formula Weight
    722.9
  • Molecular Formula
    C32H66O17
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tsikas D, et al. Gas chromatography-mass spectrometry of cis-9,10-epoxyoctadecanoic acid (cis-EODA). II. Quantitative determination of cis-EODA in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 May 25;804(2):403-12.
molnova catalog
related products
  • (2S,4S)-Sacubitril

    (2S,4S)-Sacubitril is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.

  • Diethylamino hydroxy...

    Diethylamino hydroxybenzoyl hexyl benzoate is a photostable UV-A absorber.

  • C75

    C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: 35 μM).